 |
 |

Surgical Therapy for Reflux Disease
Peter J. Kahrilas, MD
JAMA. 2001;285:2376-2378.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
With publication of a follow-up report on the Department of Veterans Affairs cooperative trial comparing long-term outcomes of medical and surgical therapy for gastroesophageal reflux disease (GERD) by Spechler et al in this issue of THE JOURNAL,1 it is clear that the decision to pursue antireflux surgery has not gotten any simpler. The status of the medical and surgical cohorts is reported 10 to 13 years after initial enrollment in the trial making this report the most complete, longest-term, and most carefully collected data available. By all standards, these patients had severe GERD, evident by the high proportion who had esophageal ulcers, strictures, or Barrett esophagus at baseline. Common wisdom argues that this is the group most likely to benefit from antireflux surgery: surgical correction is long-lasting, replaces antisecretory medications, and eliminates the subsequent cancer riskor so the argument goes.
The major findings reported by Spechler . . . [Full Text of this Article]
Author Affiliation: Department of Medicine, Northwestern University Medical School, Chicago, Ill.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Long-term Outcome of Medical and Surgical Therapies for Gastroesophageal Reflux Disease: Follow-up of a Randomized Controlled Trial
, , , , , , , , , , , , and
JAMA. ;285():2331-2338.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Surgery Is Not the Treatment of Choice for GERD
JWatch Gastroenterology 2001;2001:1-1.
FULL TEXT
Surgery Is Less Beneficial for Severe GERD than We Thought
JWatch General 2001;2001:4-4.
FULL TEXT
|